PriceTargets.com logo

Keurig Dr Pepper - KDP Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $38.36
  • Forecasted Upside: 19.72%
  • Number of Analysts: 15
  • Breakdown:
  • 0 Sell Ratings
  • 7 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$32.04 As of 11/20/2024 01:00 AM ET
▲ +0.52 (1.65%)

This chart shows the closing price for KDP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Keurig Dr Pepper Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for KDP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for KDP

Analyst Price Target is $38.36
▲ +19.72% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for Keurig Dr Pepper in the last 3 months. The average price target is $38.36, with a high forecast of $42.00 and a low forecast of $34.00. The average price target represents a 19.72% upside from the last price of $32.04.

This chart shows the closing price for KDP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 15 investment analysts is to moderate buy stock in Keurig Dr Pepper. This rating has held steady since July 2023, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
5/30/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
5/24/2024
  • 0 strong buy ratings
  • 8 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
8/22/2024
  • 0 strong buy ratings
  • 8 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
10/21/2024
  • 0 strong buy ratings
  • 8 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 7 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/28/2024BarclaysLower TargetOverweight ➝ Overweight$41.00 ➝ $39.00
10/25/2024CitigroupLower TargetBuy ➝ Buy$43.00 ➝ $40.00
10/25/2024Jefferies Financial GroupLower TargetBuy ➝ Buy$42.00 ➝ $41.00
10/25/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$41.00 ➝ $42.00
10/25/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$41.00 ➝ $40.00
10/25/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$43.00 ➝ $42.00
10/16/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$38.00 ➝ $41.00
10/11/2024BarclaysBoost TargetOverweight ➝ Overweight$37.00 ➝ $41.00
9/26/2024TD CowenBoost TargetHold ➝ Hold$35.00 ➝ $40.00
9/23/2024Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$36.00 ➝ $37.00
9/23/2024CitigroupUpgradeNeutral ➝ Buy$36.00 ➝ $43.00
9/5/2024Evercore ISIUpgradeHold
7/26/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$41.00 ➝ $41.00
7/19/2024BarclaysLower TargetOverweight ➝ Overweight$38.00 ➝ $37.00
7/10/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$37.00 ➝ $36.00
6/24/2024BNP ParibasInitiated CoverageNeutral$36.00
6/17/2024Truist FinancialUpgradeSell ➝ Hold$27.00 ➝ $34.00
6/10/2024UBS GroupBoost TargetBuy ➝ Buy$39.00 ➝ $40.00
6/5/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$39.00 ➝ $41.00
4/29/2024BarclaysBoost TargetOverweight ➝ Overweight$36.00 ➝ $38.00
4/26/2024TD CowenBoost TargetHold ➝ Hold$32.00 ➝ $35.00
4/12/2024BarclaysBoost TargetOverweight ➝ Overweight$32.00 ➝ $36.00
3/27/2024Jefferies Financial GroupLower TargetBuy ➝ Buy$37.00 ➝ $35.00
2/26/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$37.00 ➝ $34.00
2/26/2024WedbushLower TargetOutperform ➝ Outperform$37.00 ➝ $35.00
2/23/2024Royal Bank of CanadaLower TargetOutperform ➝ Outperform$42.00 ➝ $41.00
2/23/2024BarclaysLower TargetOverweight ➝ Overweight$37.00 ➝ $34.00
1/16/2024BarclaysBoost TargetOverweight ➝ Overweight$36.00 ➝ $37.00
1/3/2024Morgan StanleyDowngradeOverweight ➝ Equal Weight$37.00
12/22/2023HSBCInitiated CoverageHold$37.00
11/13/2023Jefferies Financial GroupInitiated CoverageBuy$39.00
10/30/2023BarclaysBoost TargetOverweight ➝ Overweight$34.00 ➝ $36.00
10/27/2023Morgan StanleyLower TargetOverweight ➝ Overweight$39.00 ➝ $37.00
10/12/2023BarclaysLower TargetOverweight ➝ Overweight$40.00 ➝ $34.00
10/12/2023Sanford C. BernsteinLower TargetOutperform ➝ Outperform$40.00 ➝ $37.00
10/11/2023CitigroupLower TargetNeutral ➝ Neutral$37.00 ➝ $33.00
8/15/2023UBS GroupUpgradeNeutral ➝ Buy$37.00 ➝ $42.00
7/28/2023BarclaysBoost TargetOverweight$37.00 ➝ $40.00
7/17/2023JPMorgan Chase & Co.Lower TargetOverweight$39.00 ➝ $36.00
7/11/2023WedbushLower Target$40.00 ➝ $37.00
7/6/2023Morgan StanleyUpgradeEqual Weight ➝ Overweight$37.00
4/28/2023Deutsche Bank AktiengesellschaftLower Target$36.00 ➝ $35.00
4/28/2023WedbushLower Target$43.00 ➝ $40.00
4/28/2023BarclaysLower Target$42.00 ➝ $37.00
4/18/2023JPMorgan Chase & Co.Boost Target$40.00 ➝ $41.00
4/14/2023BarclaysBoost TargetOverweight$40.00 ➝ $42.00
3/20/2023Deutsche Bank AktiengesellschaftLower Target$38.00 ➝ $36.00
2/27/2023BarclaysLower TargetOverweight$45.00 ➝ $40.00
2/16/2023CitigroupInitiated CoverageNeutral$37.00
1/26/2023JPMorgan Chase & Co.Boost TargetOverweight$40.00 ➝ $41.00
1/3/2023Wells Fargo & CompanyLower TargetOverweight$42.00 ➝ $40.00
12/6/2022Deutsche Bank AktiengesellschaftBoost TargetHold$38.00 ➝ $39.00
10/31/2022BarclaysBoost TargetOverweight$41.00 ➝ $45.00
10/31/2022Truist FinancialDowngradeHold ➝ Sell$40.00 ➝ $30.00
10/28/2022Wells Fargo & CompanyBoost TargetOverweight$41.00 ➝ $42.00
10/17/2022Deutsche Bank AktiengesellschaftBoost TargetHold$37.00 ➝ $38.00
10/10/2022WedbushInitiated CoverageOutperform$43.00
10/3/2022Wells Fargo & CompanyLower TargetOverweight$43.00 ➝ $41.00
9/27/2022The Goldman Sachs GroupDowngradeBuy ➝ Neutral$39.00 ➝ $37.00
8/1/2022UBS GroupBoost TargetNeutral$38.00 ➝ $41.00
7/20/2022JPMorgan Chase & Co.Lower Target$44.00 ➝ $42.00
6/21/2022UBS GroupDowngradeBuy ➝ Neutral$42.00 ➝ $38.00
3/22/2022Truist FinancialDowngradeBuy ➝ Hold$40.00
11/1/2021BarclaysBoost TargetOverweight$39.00 ➝ $41.00
10/29/2021Royal Bank of CanadaBoost TargetOutperform$40.00 ➝ $41.00
9/20/2021Deutsche Bank AktiengesellschaftBoost TargetHold$35.00 ➝ $36.00
6/29/2021Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$36.00 ➝ $42.00
5/3/2021Evercore ISIReiterated RatingHold
4/30/2021Credit Suisse GroupBoost TargetNeutral$30.00 ➝ $33.00
4/30/2021Morgan StanleyBoost TargetEqual Weight$34.00 ➝ $36.00
4/21/2021Deutsche Bank AktiengesellschaftBoost TargetHold$32.00 ➝ $33.00
3/19/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$33.00 ➝ $39.00
3/12/2021Morgan StanleyReiterated RatingOverweight ➝ Equal Weight
3/11/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$34.00
2/26/2021Credit Suisse GroupBoost TargetNeutral$27.00 ➝ $30.00
1/19/2021Sanford C. BernsteinInitiated CoverageOutperform$40.00
12/8/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$33.00
12/7/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$33.00
8/26/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$34.00
7/31/2020Morgan StanleyBoost TargetEqual Weight$30.00 ➝ $32.00
7/27/2020Jefferies Financial GroupBoost TargetBuy$36.00 ➝ $39.00
7/13/2020Morgan StanleyBoost TargetEqual Weight$29.00 ➝ $30.00
7/9/2020The Goldman Sachs GroupUpgradeNeutral ➝ Buy$27.00 ➝ $33.00
6/11/2020Jefferies Financial GroupUpgradeHold ➝ Buy$36.00
6/1/2020Evercore ISIUpgradeIn-Line ➝ Outperform$35.00
4/30/2020Royal Bank of CanadaReiterated RatingBuy$31.00
4/29/2020BarclaysReiterated RatingBuy
4/29/2020SunTrust BanksReiterated RatingBuy
4/28/2020CitigroupBoost TargetNeutral$28.00 ➝ $31.00
4/27/2020Morgan StanleyBoost TargetEqual Weight$25.00 ➝ $27.00
4/22/2020Royal Bank of CanadaReiterated RatingBuy$31.00
4/1/2020The Goldman Sachs GroupReiterated RatingNeutral$25.00
3/23/2020Royal Bank of CanadaReiterated RatingBuy$31.00
3/23/2020Morgan StanleyLower TargetEqual Weight$29.00 ➝ $25.00
2/26/2020Royal Bank of CanadaReiterated RatingBuy
2/23/2020Morgan StanleyUpgradeUnderweight ➝ Equal Weight$28.00 ➝ $29.00
(Data available from 11/21/2019 forward)

News Sentiment Rating

0.73 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 27 very positive mentions
  • 17 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
4/25/2024
  • 38 very positive mentions
  • 29 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 24 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 20 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 25 very positive mentions
  • 21 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 30 very positive mentions
  • 20 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 25 very positive mentions
  • 23 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 36 very positive mentions
  • 36 positive mentions
  • 9 negative mentions
  • 1 very negative mentions
Mentions as of
11/21/2024

Current Sentiment

  • 36 very positive mentions
  • 36 positive mentions
  • 9 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Keurig Dr Pepper logo
Keurig Dr Pepper Inc. owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages. Its U.S. Coffee segment offers finished goods relating to K-Cup pods, single serve brewers, specialty coffee, and ready to drink coffee products through Keurig.com website. The International segment provides sales in Canada, Mexico, the Caribbean, and other international markets from the manufacture and distribution of branded concentrates, syrup, and finished beverages; and sales in Canada from the manufacture and distribution of finished goods relating to the Company's single serve brewers, KCup pods, and other coffee products. It serves retailers, third-party bottlers and distributors, retail partners, hotel chains, office coffee distributors, and end-use consumers. The company offers its products under the Dr Pepper, Canada Dry, Green Mountain Coffee Roasters, Snapple, Mott's, The Original Donut Shop, Clamato, and Core Hydration brand name. Keurig Dr Pepper Inc. was founded in 1981 and is headquartered in Burlington, Massachusetts.
Read More

Today's Range

Now: $32.04
Low: $31.32
High: $32.06

50 Day Range

MA: $35.40
Low: $31.24
High: $38.01

52 Week Range

Now: $32.04
Low: $28.61
High: $38.28

Volume

8,493,157 shs

Average Volume

9,253,835 shs

Market Capitalization

$43.46 billion

P/E Ratio

19.42

Dividend Yield

2.91%

Beta

0.63

Frequently Asked Questions

What sell-side analysts currently cover shares of Keurig Dr Pepper?

The following Wall Street research analysts have issued research reports on Keurig Dr Pepper in the last year: Barclays PLC, BNP Paribas, Citigroup Inc., Deutsche Bank Aktiengesellschaft, Evercore ISI, HSBC Holdings plc, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Royal Bank of Canada, TD Cowen, Truist Financial Co., UBS Group AG, Wedbush, and Wells Fargo & Company.
View the latest analyst ratings for KDP.

What is the current price target for Keurig Dr Pepper?

0 Wall Street analysts have set twelve-month price targets for Keurig Dr Pepper in the last year. Their average twelve-month price target is $38.36, suggesting a possible upside of 19.7%. Wells Fargo & Company has the highest price target set, predicting KDP will reach $42.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $34.00 for Keurig Dr Pepper in the next year.
View the latest price targets for KDP.

What is the current consensus analyst rating for Keurig Dr Pepper?

Keurig Dr Pepper currently has 7 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for KDP.

What other companies compete with Keurig Dr Pepper?

Other companies that are similar to Keurig Dr Pepper include Anheuser-Busch InBev SA/NV, Duckhorn Portfolio, Westrock Coffee, BRC and LQR House. Learn More about companies similar to Keurig Dr Pepper.

How do I contact Keurig Dr Pepper's investor relations team?

Keurig Dr Pepper's physical mailing address is 53 SOUTH AVENUE, BURLINGTON MA, 01803. The company's listed phone number is (877) 208-9991 and its investor relations email address is [email protected]. The official website for Keurig Dr Pepper is www.keurigdrpepper.com. Learn More about contacing Keurig Dr Pepper investor relations.